|
1
|
Matei DE and Nephew KP: Epigenetic
therapies for chemoresensitization of epithelial ovarian cancer.
Gynecol Oncol. 116:195–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gilbert L, Basso O, Sampalis J, Karp I,
Martins C, Feng J, Piedimonte S, Quintal L, Ramanakumar AV,
Takefman J, et al: Assessment of symptomatic women for early
diagnosis of ovarian cancer: Results from the prospective DOvE
pilot project. Lancet Oncol. 13:285–291. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raja FA, Counsell N, Colombo N, Pfisterer
J, du Bois A, Parmar MK, Vergote IB, Gonzalez-Martin A, Alberts DS,
Plante M, et al: Platinum versus platinum-combination chemotherapy
in platinum-sensitive recurrent ovarian cancer: A meta-analysis
using individual patient data. Ann Oncol. 24:3028–3034. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vecchione A, Belletti B, Lovat F, Volinia
S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC,
Pellegrini P, et al: A microRNA signature defines chemoresistance
in ovarian cancer through modulation of angiogenesis. Proc Natl
Acad Sci. 110:9845–9850. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Galluzzi L, Morselli E, Kepp O, Vitale I,
Rigoni A, Vacchelli E, Michaud M, Zischka H, Castedo M and Kroemer
G: Mitochondrial gateways to cancer. Mol Aspects Med. 31:1–20.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schoenlein PV, Periyasamy-Thandavan S,
Samaddar JS, Jackson WH and Barrett JT: Autophagy facilitates the
progression of Eralpha-positive breast cancer cells to antiestrogen
resistance. Autophagy. 5:400–403. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ning L, Guo-Chun Z, Sheng-Li A, Xue-Rui L,
Kun W, Jian Z, Chong-Yang R, Ling-Zhu W and Hai-Tong L: Inhibition
of autophagy induced by PTEN loss promotes intrinsic breast cancer
resistance to trastuzumab therapy. Tumor Biol. 37:5445–5454. 2016.
View Article : Google Scholar
|
|
9
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Macintosh RL and Ryan KM: Autophagy in
tumour cell death. Semin Cancer Biol. 23:344–351. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Glick D, Barth S and Macleod KF:
Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liang B, Kong D, Liu Y, Liang N, He M, Ma
S and Liu X: Autophagy inhibition plays the synergetic killing
roles with radiation in the multi-drug resistant SKVCR ovarian
cancer cells. Radiat Oncol. 7:2132012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Libby G, Donnelly LA, Donnan PT, Alessi
DR, Morris AD and Evans JM: New users of metformin are at low risk
of incident cancer: A cohort study among people with type 2
diabetes. Diabetes Care. 32:1620–1625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chan DK and Miskimins WK: Metformin and
phenethyl isothiocyanate combined treatment in vitro is cytotoxic
to ovarian cancer cultures. J Ovarian Res. 5:192012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang P, Kang D, Cao W, Wang Y and Liu Z:
Diabetes mellitus and risk of hepatocellular carcinoma: A
systematic review and meta-analysis. Diabetes Metab Res Rev.
28:109–122. 2011. View Article : Google Scholar
|
|
16
|
Bonanni B, Puntoni M, Cazzaniga M, Pruneri
G, Serrano D, Guerrieri-Gonzaga A, Gennari A, Trabacca MS,
Galimberti V and Veronesi P: Dual effects of metformin on breast
cancer proliferation in a randomized trial. J Clin Oncol.
30:2593–2600. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu Z, Zhao G, Xie G, Zhao L, Chen Y, Yu H,
Zhang Z, Li C and Li Y: Metformin and temozolomide act
synergistically to inhibit growth of glioma cells and glioma stem
cells in vitro and in vivo. Oncotarget. 6:32930–32943. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sliwinska A, Rogalska A, Marczak A,
Kasznicki J and Drzewoski J: Metformin, but not sitagliptin,
enhances WP 631-induced apoptotic HepG2 cell death. Toxicol In
Vitro. 29:1116–1123. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jara JA and López-Muñoz R: Metformin and
cancer: Between the bioenergetic disturbances and the antifolate
activity. Pharmacol Res. 101:102–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiao H, Ma X, Feng W, Fu Y, Lu Z, Xu M,
Shen Q, Zhu Y and Zhang Y: Metformin attenuates cardiac fibrosis by
inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc Res.
87:504–513. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang YC, Hsu CC, Lin WC, Yin TK, Huang
CW, Wang PW, Chang HH and Chiu NT: Effects of metformin on the
cerebral metabolic changes in type 2 diabetic patients. Scientific
World Journal. 2014:6943262014.PubMed/NCBI
|
|
23
|
Bowker SL, Majumdar SR, Veugelers P and
Johnson JA: Increased cancer-related mortality for patients with
type 2 diabetes who use sulfonylureas or insulin. Diabetes Care.
29:254–258. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Algire C, Amrein L, Zakikhani M, Panasci L
and Pollak M: Metformin blocks the stimulative effect of a
high-energy diet on colon carcinoma growth in vivo and is
associated with reduced expression of fatty acid synthase. Endocr
Relat Cancer. 17:351–360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jiralerspong S, Palla SL, Giordano SH,
Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung MC, Hortobagyi
GN and Gonzalez-Angulo AM: Metformin and pathologic complete
responses to neoadjuvant chemotherapy in diabetic patients with
breast cancer. J Clin Oncol. 27:3297–3302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hadad SM, Coates P, Jordan LB, Dowling RJ,
Chang MC, Done SJ, Purdie CA, Goodwin PJ, Stambolic V,
Moulder-Thompson S and Thompson AM: Evidence for biological effects
of metformin in operable breast cancer: Biomarker analysis in a
pre-operative window of opportunity randomized trial. Breast Cancer
Res Treat. 150:149–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yerrabothala S, Shaaban H, Capo G,
Maroules M and Debari VA: The impact of diabetes mellitus on breast
cancer outcomes: A single center retrospective study. Pathol Oncol
Res. 20:209–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hu YL, Jahangiri A, Delay M and Aghi MK:
Tumor cell autophagy as an adaptive response mediating resistance
to treatments such as antiangiogenic therapy. Cancer Res.
72:4294–4299. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J and Wu GS: Role of autophagy in
cisplatin resistance in ovarian cancer cells. J Biol Chem.
289:17163–17173. 2014. View Article : Google Scholar : PubMed/NCBI
|
